Category: united states

ORI investigating University of Florida ob-gyn researcher accused of misconduct

A prominent researcher at the University of Florida is under federal investigation for research misconduct and has lost at least one paper as a result of the fraud.

The researcher, Nasser Chegini, was a professor of obstetrics and gynecology at the U of Florida until about six months ago, when he retired, according to the chair’s office. Nasser has received at least $4 million in federal grant funding, according to the university.

The retracted paper, “MicroRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells,” was published in 2010 by Molecular Human Reproduction. The authors were Qun Pan and Xiaoping Luo and Chegini.

As the notice explains: Continue reading ORI investigating University of Florida ob-gyn researcher accused of misconduct

High school whiz kid retracts PLoS ONE herd immunity paper

Georgette speaking at the Davidson Institute’s award ceremony, Library of Congress, 2008

It’s pretty impressive to publish two peer-reviewed papers on complicated vaccination models while you’re still in high school. So it’s not surprising that Nathan Georgette, who grew up outside of Jacksonville, Florida, earned a prestigious fellowship from the Davidson Institute for Talent Development.

But perhaps even more impressive is realizing you’ve made a fundamental error in one of those studies, and retracting it while you’re still a college senior at Harvard. Continue reading High school whiz kid retracts PLoS ONE herd immunity paper

Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons

We’ve written about mega-corrections that allow scientists to retrace virtually all of their steps yet preserve their publications as supposedly legitimate. And we’ve seen plenty of corrections that allow authors to assert that their conclusions are correct when evidently important pieces of data are themselves unreliable.

Now comes a correction that seems to us to strike the right chords, given the fact that editors are to a large extent at the mercy of authors in these situations. Continue reading Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons

The domino effect: More retractions of papers that cited retracted PLoS ONE GMO cassava study

Last month, we reported on a PLoS ONE paper about genetically modified cassava — or, more correctly, allegedly GMO cassava — that was being retracted because data “could not be found.” We have an update on that story, namely that a paper relying on materials from that lab will be retracted, and that authors of a review that included a figure from the graduate student who claimed to have done the work will retract part of their paper.

As a Retraction Watch commenter on our earlier post noted, referring to Claude Fauquet, the PI of the Danforth Center lab where graduate student Mohammad Abhary worked: Continue reading The domino effect: More retractions of papers that cited retracted PLoS ONE GMO cassava study

Another retraction for Anil Potti, with an inscrutable notice

We’ve seen a lot of retraction notices for work by Anil Potti — 10, to be precise, along with 7 corrections and one partial retraction notice. As notices go, they tend to be pretty complete. So when we saw one in CHEST for this 2008 abstract, we were expecting something similar.

Instead, we were confused.

Here’s the notice: Continue reading Another retraction for Anil Potti, with an inscrutable notice

JAMA’s first-ever Expression of Concern appears for hip protector study

JAMA has issued its first-ever Expression of Concern over a 2007 study of hip protectors in the elderly that came under scrutiny from Federal regulators.

As the Boston Globe was first to report yesterday, the journal’s editor and executive deputy editor wrote in a notice published online: Continue reading JAMA’s first-ever Expression of Concern appears for hip protector study

Solar energy paper retracted for text, data misuse

Renewable and Sustainable Energy Reviews has retracted a 2008 paper by a group from the United States and Botswana, citing plagiarism and unauthorized use of data.

The article, “Solar chimney power generation project—The case for Botswana,” discussed a project by the Botswanan military to develop a power plant based on the chimney design. The paper is no longer available online, but we found this Wikipedia entry that mentions it: Continue reading Solar energy paper retracted for text, data misuse

Immunology paper retracted because “documents were not archived with due diligence”

A group of researchers from Austria, Canada, Germany, and the U.S. have retracted a 2008 paper in the Journal of Immunology after being unable to verify the contents of some key figures.

Here’s the notice: Continue reading Immunology paper retracted because “documents were not archived with due diligence”

Reused figures lead to two chemistry retractions, one correction

Why just have three peer-reviewed publications when you can reuse figures to publish a fourth?

That’s the sort of thinking that got one research group slapped with a retraction of their 2009 study, “Carbon Nanotubes Are Able To Penetrate Plant Seed Coat and Dramatically Affect Seed Germination and Plant Growth.”

The journal ACS Nano, published by the American Chemical Society, issued the retraction on Aug. 20: Continue reading Reused figures lead to two chemistry retractions, one correction

Study linking antidepressants to diabetes retracted when authors publish it twice

A group of researchers from Texas and Zimbabwe has lost a paper after they tried publishing it twice — first in the European Journal of Clinical Pharmacology, and then in the International Journal of Clinical Pharmacy.

Here’s the notice: Continue reading Study linking antidepressants to diabetes retracted when authors publish it twice